5/23/2022
Anokion, CDF Partner, Announces Clinical Trial Results
Anokion SA released successful results from their Phase 1 ACeD clinical trial and they will be moving forward with Phase 2 trials later this year.
Continue ReadingFeatured News
Tag: Anokion
3/9/2021
Assessment of KAN-101 in Celiac Disease (ACeD) Study Open
The ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.
Continue Reading12/10/2020
ACeD Study: Investigational Drug KAN-101 in Celiac Patients
The ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.
Continue Reading7/4/2020
KAN-101 Phase 1 Clinical Trial Recruiting Now
The ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.
Continue ReadingRecent Posts
- Celiac Disease Foundation and SSCD Submit Comments on FDA Draft Guidance for Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet
- Celiac Disease Foundation Excellence in Celiac Disease Research and Young Investigator Prize Recipients Donate Prize Funds to Benefit the Celiac Community
- CDF Announces Recipients of Inaugural Celiac Disease Research Prizes
- New Tool in Development to Improve Pediatric Celiac Disease Research - Marilyn's Message April 2022
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Marilyn’s Message
- Monthly eNewsletter
- Research News
- Trending Topics
Marilyn's Message
5/11/2022
Read moreCDF Announces Recipients of Inaugural Celiac Disease Research Prizes
